FDA approves drug for hospital-acquired pneumonia

On May 23, the FDA approved a new drug intended to treat hospital-acquired pneumonia and ventilator-associated pneumonia caused by Acinetobacter baumannii-calcoaceticus, a critical bacterial pathogen. 

Read the full post at Becker's Hospital Review - Healthcare News